Pharmaceutical Commerce - January/February 2012

Manufacturers are reviving their serialization plans

February 22, 2012

The pioneering firms that installed serialization and track-and-trace systems are being joined by a fast follower crowd, but an industry-wide commitment is still in the future

Obama seeks to strengthen supply chain security, protect US intellectual property

January 26, 2012

But will anti-terrorism concerns trump commercial interests?

Specialty pharma contracting provider makes prior authorization paperwork easy

January 24, 2012

Armada Health Care streamlines prior auth with free ApproveRx service

HDMA updates its barcode guidance for wholesaler members

January 24, 2012

New guidelines prepare for eventual item-level serialization, while embodying FDA guidance for barcoded hospital-supply products

Verify Brand re-enters life-sciences serialization market with dedicated software offering

January 24, 2012

Company is bringing its expertise from outside life sciences

New York State considers real-time reporting of controlled-substances prescribing

January 24, 2012

Aim is to reduce ‘doctor shopping’ for prescriptions, and to better monitor patients and addicts’ health; potential system highlights data availability

UPS Healthcare Logistics adds to network with an Italian acquisition

January 11, 2012

Purchase of Pieffe Group, combined with new facility launches, brings UPS capacity nearly to 5 million sq.ft. worldwide; more expected in 2012

US wholesaler-distributor network saves manufacturers $42 billion annually, says HDMA research center

January 11, 2012

New edition of 'The Role of Distributors,' plus a new report on specialty pharmaceutical distribution, highlight distributors’ roles in healthcare

Gartner 2011 Healthcare Supply Chain Top 25 puts Cardinal Health at No. 1

January 11, 2012

Analysis combines financial and operational performance, and industry reputation, among manufacturers, distributors and healthcare systems

Digital marketing captures a greater 'share of mind' among pharma marketing, says Cutting Edge Information

January 11, 2012

Pharma companies are beginning to staff up internally—in part out of dissatisfaction with the capabilities of outside marketing agencies they employ

The shape of the home infusion industry

January 11, 2012

Home infusion association gathers member data, measuring variations in business practices

California biotech CEOs want: more money; less FDA regulation

January 10, 2012

Preview of annual PwC survey finds that disease foundations and NGOs are a growing part of biotech investment

IMS Health/SDI integration is essentially approved by FTC; Thomson Reuters reassesses divestiture

January 10, 2012

More reshuffling of healthcare-analytics market is in store

The global distribution perspective

January 09, 2012

Rapidly rising healthcare-products trade is almost being matched by increased regulatory scrutiny

Industry collaborates on logistics and supply chain security

January 08, 2012

With Rx-360 already at critical mass and delivering results, the call is out for more participation

Aggregate Spending Rules Arrive, But Industry Is Still Gearing Up

January 08, 2012

The 'Sunshine Act' provisions of the Affordable Care Act require records to be kept beginning Jan. 1

Battle lines draw up between PBMs and manufacturers who use copay coupons

January 08, 2012

PCMA study estimates additional $32 billion in added healthcare costs through 2021; coupons 'lure consumers to switch from generics to expensive brands'

The R&D Decline Is Worse Than Thought, Says Oliver Wyman

January 08, 2012

White paper points out the drop in pipeline performance; suggests a new direction is necessary

Brand Owner-CMO Collaboration Is Growing--But Is Far From Mature

January 08, 2012

The long-recommended practice of shared data and plans between biopharma companies and their contract manufacturing organizations (CMOs) is beginning to take hold

Understanding Class of Trade Concepts

January 08, 2012

‘Class of Trade’ is a murky element of contracts and channel analytics that can have important legal implications

Generics Manufacturers Grapple With Tight Economics

January 07, 2012

But the global picture is sunny as most of the global market growth benefits the generic makers

The potential of translational research for new medicines

January 07, 2012

The proposed federal National Center for Advancing Translational Sciences holds promise for drug development

FDA offers draft guidance on unsolicited requests for off-label drug information

January 06, 2012

The basic principle is: say as little as possible in public—and document what is said privately

FDA achieves part of its 'class wide' REMS for immediate-release fentanyl

January 06, 2012

Manufacturers will share a common access program